-
Namodenoson (CF-102) is a selective A3 adenosine receptor (A3AR) agonist.
-
Temoporfin, a photosensitizer agent, can be used for the research of squamous cell carcinoma of the head and neck.
-
Seliciclib, a potent, selective and orally active CDKs inhibitor, preferentially inhibits CDK2, CDK7 and CDK9.
-
Vistusertib is an ATP competitive mTOR inhibitor with an IC50 of 2.81 nM. AZD2014 inhibits both mTORC1 and mTORC2 complexes.
-
Epoxomicin is an epoxyketone-containing natural product and a selective and irreversible proteasome inhibitor. Cross the blood-brain barrier.
-
5-Azacytidine is a DNMT inhibitor. 5-Azacytidine can be used for the research of myelodysplastic syndrome.
-
Pimasertib is a highly selective, ATP non-competitive allosteric orally available MEK1/2 inhibitor with antitumor activies.
-
Epothilone B, a non-taxane-related and nonneurotoxic microtubule stabilizer, can be used for the research of breast cancer.
-
Bisantrene is topoisomerase II poisons and DNA intercalators. Bisantrene intercalates with and disrupts the configuration of DNA.
-
Splitomicin is a cell-permeable, potent inhibitor of SIR2. Splitomicin inhibits the aggregation of human platelets.
Categories
Diseases
Others
Archives
- March 2023 (14)
- February 2023 (18)
- January 2023 (14)
- December 2022 (21)
- November 2022 (14)
- October 2022 (16)
- September 2022 (13)
- August 2022 (13)
- July 2022 (12)
- June 2022 (12)
- May 2022 (13)
- April 2022 (10)
- March 2022 (9)
- February 2022 (8)
- January 2022 (14)
- December 2021 (13)
- November 2021 (13)
- October 2021 (13)
- September 2021 (11)
- August 2021 (17)
- July 2021 (19)
- June 2021 (18)
- May 2021 (18)
- April 2021 (17)
- March 2021 (19)
- February 2021 (16)
- January 2021 (20)
- December 2020 (16)
- November 2020 (16)
- October 2020 (17)
- September 2020 (18)
- August 2020 (17)
- July 2020 (18)
- June 2020 (17)
- May 2020 (17)
- April 2020 (18)
- March 2020 (17)
- February 2020 (14)
- January 2020 (16)
- December 2019 (19)
- November 2019 (15)
- October 2019 (17)
- September 2019 (28)
- August 2019 (31)
- July 2019 (31)
- June 2019 (32)
- May 2019 (31)
- April 2019 (32)
- March 2019 (7)